NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Department of Health and Human Services
This Notice of Funding Opportunity (NOFO) invites applications to use NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of Heart, Lung, Blood, and Sleep (HLBS) disorders. No funding will be provided under this NOFO. The genomic data and related phenotypic data will be deposited in a public NIH-designated controlled-access database such as the database for Genotypes and Phenotypes (dbGaP) and NHLBIs BioData Catalyst (BDC). The overall goal is to move from simply cataloguing genetic associations to understanding how genetic factors contribute to HLBS diseases
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
09/22/2025
Closes
2028-05-08
Eligibility
Eligibility
Public housing authorities/Indian housing authoritiesSpecial district governmentsState governmentsPrivate institutions of higher educationNative American tribal governments (Federally recognized)Independent school districtsOthers (see text field entitled "Additional Information on Eligibility" for clarification)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationFor profit organizations other than small businessesCity or township governmentsCounty governmentsPublic and State controlled institutions of higher educationNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationSmall businesses
Program
Funding area
Health - HL
Opportunity #
PAR-25-447
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov